Heron Therapeutics Inc HRTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
14.00quote price arrow up+0.15 (+1.08%)
Volume
87,626
Close
13.85quote price arrow down-1.68 (-10.85%)
Volume
8,282,719
52 week range
12.52 - 22.40

...

Loading . . .
  • Open15.84
  • Day High15.89
  • Day Low13.12
  • Prev Close15.53
  • 52 Week High22.40
  • 52 Week High Date12/28/20
  • 52 Week Low12.52
  • 52 Week Low Date06/29/20

Key Stats

  • Market Cap1.41B
  • Shares Out101.83M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-34.56

KEY STATS

  • Open15.84
  • Day High15.89
  • Day Low13.12
  • Prev Close15.53
  • 52 Week High22.40
  • 52 Week High Date12/28/20
  • 52 Week Low12.52
  • 52 Week Low Date06/29/20
  • Market Cap1.41B
  • Shares Out101.83M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-34.56

RATIOS/PROFITABILITY

  • EPS (TTM)-2.51
  • P/E (TTM)-5.52
  • Fwd P/E (NTM)-6.49
  • EBITDA (MRQ)-224.578M
  • ROE (MRQ)-81.29%
  • Revenue (MRQ)83.26M
  • Gross Margin (MRQ)58.23%
  • Net Margin (MRQ)-274.23%
  • Debt To Equity (MRQ)3.85%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Heron Therapeutics Inc

Related Video

VIDEO1:1201:12
Final Trades: Thermo Fisher, Kinder Morgan, EQT Corp. & more

Profile

MORE
Heron Therapeutics, Inc. is a biotechnology company engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Company's product candidates include SUSTOL, HTX-019 and HTX-011. All of its product candidates utilize science and technology platforms, including its Biochronomer drug delivery technology. The Company's SUSTOL (granisetron) injection, extended release is being developed for the prevention of both acute and delayed...
Barry Quart Pharm.D.
Chairman
John Poyhonen
President
David Szekeres
Chief Operating Officer
Lisa Peraza
Chief Accounting Officer
Kimberly Manhard
Executive Vice President
John Arthur Ph.D.
Vice President
Address
4242 Campus Point Ct Ste 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
CDMO
Avid Bioservices Inc
20.09+0.81+4.20%
SGMO
Sangamo Therapeutics Inc
10.85+0.45+4.33%
TBPH
Theravance Biopharma Inc
18.72UNCHUNCH
MYOV
Myovant Sciences Ltd
21.26+0.87+4.27%
CYTK
Cytokinetics Inc
25.93+0.70+2.77%